Male Breast Carcinoma: II. A study of the total material reported to the Swedish Cancer Registry 1958--1967 with respect to treatment, prognostic factors and survival

Racial differences in cancer of the male breast — 15 year experience in the Detroit Metropolitan Area

“…A number of reports have described the clinical presentation and treatment of breast cancer in men as well as incidence and survival patterns. In some studies, increased age at diagnosis has been correlated with worse survival [3,4], while in others either the relative mortality from breast cancer was improved in older men [5], or no age effect was seen [6,7].…”

“…In several retrospective analyses, clinical outcomes were assessed in patients undergoing radical versus more conservative surgical approaches [7,8,10,11]. While many centers have reported on large cohorts of men ranging in size from 100 to 1500 [3,5,6,7,12,13], few have addressed the question of racial differences in prognosis.…”

Therapiestrategien beim Mammakarzinom des Mannes

“…Während einige Autoren keinen Vorteil in der zusätzlichen Nachbestrahlung sehen [37,38], wurde ein solcher Vorteil in anderen Serien beobachtet [36,39]. Ein Überlebensvorteil konnte jedoch nicht nachgewiesen werden [32,36,40].…”

“…Als Therapieziel gelten dabei neben der lokalen Tumorkontrolle die prognostische Information sowie die Indikationsstellung zur medikamentösen Adjuvanstherapie. Neue Konzepte der selektiven Dissektion lediglich tumorbefallener axillärer Lymphknoten nach Evaluierung des prädiktiven Grenzlymphknotens könnten in Zukunft zu geänderten Therapiestrategien führen [45,46] [17,18,37]. Die häufigste Form der Manifestation sind subkutane Knoten in Nachbarschaft der Narbenregion.…”

Synchronous Bilateral Primary Male Breast Carcinoma with Hyperprolactinemia

“…Bleomycin was also omitted because of a possible increased toxicity during renal failure (8)(9)(10). Fluid overload was avoided to spare his heart while keeping the diuresis above 100 ml/h to spare the kideys.…”